VASODILATOR - ANTI-HYPERTENSIVE DRUG

被引：0
作者：
SAFAR, M
SIMON, A
PIPEAU, A
机构：
来源：
NOUVELLE PRESSE MEDICALE | 1980年 / 9卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：677 / 679
页数：3
相关论文
共 24 条
[1]   CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].
BRAVO, EL ;
TARAZI, RC .
HYPERTENSION, 1979, 1 (01) :39-46
[2]   RELATIONSHIPS BETWEEN CARDIAC-OUTPUT, HEART-RATE AND BLOOD-VOLUME IN ESSENTIAL HYPERTENSION [J].
CHAU, NP ;
SAFAR, ME ;
WEISS, YA ;
LONDON, GM ;
SIMON, AC ;
MILLIEZ, PL .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 54 (02) :175-180
[3]  
COHN JN, 1977, NEW ENGL J MED, V297, P27
[4]  
FOLKOW B, 1971, CLIN SCI, V41, P1
[5]   DRUG-THERAPY - PRAZOSIN [J].
GRAHAM, RM ;
PETTINGER, WA .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (05) :232-236
[6]   INTRAVENOUS USE OF DIAZOXIDE IN TREATMENT OF SEVERE HYPERTENSION [J].
HAMBY, WM ;
JANKOWSKI, GJ ;
POUGET, JM ;
DUNEA, G ;
GANTT, CL .
CIRCULATION, 1968, 37 (02) :169-+
[7]  
KAPLAN NM, 1978, CLIN HYPERTENSION, P49
[8]   DRUG-THERAPY - HYDRALAZINE [J].
KOCHWESER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (06) :320-323
[9]  
LARAGH JH, 1977, FED P FED AM SOC EXP, V36, P1871
[10]  
LEVENSON JA, 1979, EFFECT INTRAVENOUS N
123